HB0043

· Shanghai Huaota Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HB0043, covering 2025-05-31 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris. [Phase 1, Phase 2]

See pricing